These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 2751617)
1. Toxicities of Na2B12H11SH and Na4B24H22S2 in mice. Marshall PG; Miller ME; Grand S; Micca PL; Slatkin DN Basic Life Sci; 1989; 50():333-51. PubMed ID: 2751617 [No Abstract] [Full Text] [Related]
2. Distributions of sulfhydryl borane monomer and dimer in rodents and monomer in humans: boron neutron capture therapy of melanoma and glioma in boronated rodents. Slatkin DN; Joel DD; Fairchild RG; Micca PL; Nawrocky MM; Laster BH; Coderre JA; Finkel GC; Poletti CE; Sweet WH Basic Life Sci; 1989; 50():179-91. PubMed ID: 2751607 [No Abstract] [Full Text] [Related]
3. Uptake of boron into human gliomas of athymic mice and into syngeneic cerebral gliomas of rats after intracarotid infusion of sulfhydryl boranes. Joel DD; Slatkin DN; Micca PL; Nawrocky MM; Dubois T; Velez C Basic Life Sci; 1989; 50():325-32. PubMed ID: 2535636 [No Abstract] [Full Text] [Related]
4. Pharmacokinetics of BSH in patients with glioma. Harkness WF; Adams CB Strahlenther Onkol; 1989; 165(2-3):242-4. PubMed ID: 2928947 [No Abstract] [Full Text] [Related]
5. Distribution of boron in two (B12H11SH)2--infused patients with malignant glioma. Slatkin DN; Finkel GC; Micca PL; Laster BH; Poletti CE; Sweet WH Strahlenther Onkol; 1989; 165(2-3):244-6. PubMed ID: 2928948 [No Abstract] [Full Text] [Related]
6. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption. Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):663-72. PubMed ID: 9112465 [TBL] [Abstract][Full Text] [Related]
7. A comparative study on the pharmacokinetics and biodistribution of boronated porphyrin (BOPP) and sulfhydryl boron hydride (BSH) in the RG2 rat glioma model. Ceberg CP; Brun A; Kahl SB; Koo MS; Persson BR; Salford LG J Neurosurg; 1995 Jul; 83(1):86-92. PubMed ID: 7782856 [TBL] [Abstract][Full Text] [Related]
8. Accumulation of 10B in the central degenerative areas of human glioma and colon carcinoma spheroids after sulfhydryl boron hydride administration. Pettersson OA; Carlsson J; Grusell E Cancer Res; 1992 Mar; 52(6):1587-91. PubMed ID: 1540968 [TBL] [Abstract][Full Text] [Related]
9. Proposed clinical trial studying the pharmacokinetics of B.S.H. Harkness WF Basic Life Sci; 1989; 50():49-51. PubMed ID: 2665733 [No Abstract] [Full Text] [Related]
10. Boron neutron capture therapy: boron biodistribution and pharmacokinetics of Na2B12H11SH in patients with glioblastoma. Haselsberger K; Radner H; Pendl G Cancer Res; 1994 Dec; 54(24):6318-20. PubMed ID: 7987820 [TBL] [Abstract][Full Text] [Related]
11. The in vitro effect of sodium mercaptoundecahydrododecaborate (borocaptate) on sulfhydryl groups of different rat tissues. Buchar E; Horn V; Kameníková L; Janku I Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):619-22. PubMed ID: 7746022 [TBL] [Abstract][Full Text] [Related]
12. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine. Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT. Yokoyama K; Miyatake S; Kajimoto Y; Kawabata S; Doi A; Yoshida T; Asano T; Kirihata M; Ono K; Kuroiwa T J Neurooncol; 2006 Jul; 78(3):227-32. PubMed ID: 16557351 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and tissue distribution of the sulfhydryl boranes (monomer and dimer) in glioma-bearing rats. Joel D; Slatkin D; Fairchild R; Micca P; Nawrocky M Strahlenther Onkol; 1989; 165(2-3):167-70. PubMed ID: 2928940 [No Abstract] [Full Text] [Related]
15. Cell culture and animal studies for intracerebral delivery of borocaptate in liposomal formulation. Ji B; Chen W; Lu DR; Halpern DS Drug Deliv; 2001; 8(1):13-7. PubMed ID: 11280438 [TBL] [Abstract][Full Text] [Related]
16. Kidney function changes in rats after single-dose administration of borocaptate sodium. Horn V; Buchar E; Janků I Physiol Res; 1997; 46(4):279-83. PubMed ID: 9728493 [TBL] [Abstract][Full Text] [Related]
17. Is there a future for neutron capture therapy? Allen BJ Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):908. PubMed ID: 9240662 [No Abstract] [Full Text] [Related]
18. Clinical phase-I study of Na2B12H11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT). Haritz D; Gabel D; Huiskamp R Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1175-81. PubMed ID: 8175403 [TBL] [Abstract][Full Text] [Related]
19. Biodistribution of boron in dogs with spontaneous intracranial tumors following borocaptate sodium administration. Kraft SL; Gavin PR; Leathers CW; DeHaan CE; Bauer WF; Miller DL; Dorn RV; Griebenow ML Cancer Res; 1994 Mar; 54(5):1259-63. PubMed ID: 8118814 [TBL] [Abstract][Full Text] [Related]
20. Na2B12H11SH (BSH) in combination with systemic hyaluronidase: a promising concept for boron neutron capture therapy for glioblastoma. Haselsberger K; Radner H; Pendl G Neurosurgery; 1996 Aug; 39(2):321-5; discussion 325-6. PubMed ID: 8832669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]